clopidogrel oral and gentamicin-prednisolone opht

clopidogrel oral will increase the level or effect of gentamicin-prednisolone opht by affecting hepatic/intestinal enzyme CYP3A4 metabolism. CYP3A4 inducers may increase the metabolism of clopidogrel to its active metabolite. Monitor patients for potential increase in antiplatelet effects when CYP3A4 inducers are used in combination with clopidogrel

gentamicin-prednisolone opht and clopidogrel oral

gentamicin-prednisolone opht will increase the level or effect of clopidogrel oral by affecting hepatic/intestinal enzyme CYP3A4 metabolism. CYP3A4 inducers may increase the metabolism of clopidogrel to its active metabolite. Monitor patients for potential increase in antiplatelet effects when CYP3A4 inducers are used in combination with clopidogrel

Significant

Minor

Interaction is unlikely, minor, or nonsignificant

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for informational purposes only. This tool may not cover all possible drug interactions. Please check with a physician if you have health questions or concerns. Although we attempt to provide accurate and up-to-date information, no guarantee is made to that effect.